Zhongda Hospital, Southeast University
Zhongda Hospital, Southeast University
Nanjing, Jiangsu, China15 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Epidural Spinal Cord Stimulation for Respiratory Recovery in Cervical SCI | Respiration Disorders, central nervous system disorder, injury, nervous system disorder, nervous system injury, respiratory failure, respiratory system disorder, spinal cord disorder, spinal cord injury | Recruiting | Not applicable | 2026-09-04 | NCT07722130 | |
| Trunk Inclination, Positive End-expiratory Pressure, and Lung Recruitability | Respiration Disorders, adult acute respiratory distress syndrome, lung disorder, respiratory system disorder | Recruiting | Not stated | 2026-09-03 | NCT07504731 | |
| Personalized Ventilation Based on Ventilation-perfusion Mismatch and Lung Recruitability | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Respiratory Aspiration, adult acute respiratory distress syndrome, lung disorder, respiratory system disorder | Recruiting | Not stated | 2026-09-03 | NCT06430554 | |
| Epidural Spinal Cord Stimulation for Respiratory Recovery in Brain Injury | Craniocerebral Trauma, Respiration Disorders, brain disorder, brain injury, central nervous system disorder, injury, nervous system disorder, nervous system injury, respiratory failure, respiratory system disorder | Not yet recruiting | Not applicable | 2026-08-14 | NCT07766681 | |
| Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients | Heart Failure Due to Coronary Artery Disease | Not yet recruiting | Phase 3 | 2026-08-05 | NCT07725484 | |
| PyroEVs/PLIN3 Mediate Lipid Droplet-Mitochondrial Coupling in Sepsis Endothelial Injury | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome | Recruiting | Not stated | 2026-07-27 | NCT07727265 | |
| Immune Mechanisms and ECMO Strategies for Moderate-to-Severe ARDS | Respiration Disorders, adult acute respiratory distress syndrome, lung disorder, respiratory system disorder | Recruiting | Not stated | 2026-07-27 | NCT07726940 | |
| Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative Colitis Patients Undergoing Initial Biologic Therapy(PRECAL) | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Enrolling by invitation | Not stated | 2026-07-23 | NCT07721441 | |
| Gelaspan vs Crystalloid Therapy in Sepsis | Infections, Inflammation, Intraabdominal Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome | Recruiting | Phase 4 | 2026-03-20 | NCT07172451 | |
| Enteral Nutrition Delivery in Prone Position Ventilated Patients With Moderate to Severe ARDS | ARDS | Recruiting | Not applicable | 2026-01-23 | NCT07362537 | |
| Sigh Ventilation in Cardiac Surgery | Cardiac Surgery in Adult Patient; Postoperative Pulmonary Complications (PPCs) | Recruiting | Not applicable | 2025-11-18 | NCT07024420 | |
| Atezolizumab Plus Bevacizumab Combined With Locoregional Therapies in Unresectable Hepatocellular Carcinoma (ISMIO-001) | Unresectable Hepatocellular Carcinoma | Active, not recruiting | Not stated | 2025-10-02 | NCT07204327 | |
| Effect of Xuebijing InjecTion on Outcomes in Sepsis Patients Under Real-World Conditions(EXIT-SEP REAL) | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome | Not yet recruiting | Not stated | 2025-07-17 | NCT07069894 | |
| Outcomes of Sepsis Patients in China (CHINA-SEP) | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome | Not yet recruiting | Not stated | 2025-07-15 | NCT07066553 | |
| SIRT Versus cTACE for Unresectable HCC (CHANCE2506) | Unresectable Hepatocellular Carcinoma | Recruiting | Not applicable | 2025-04-09 | NCT06909708 |